Mechanisms of cough in Mycobacterium tuberculosis transmission
Mechanisms of cough in Mycobacterium tuberculosis transmission
批准号:
10185506
负责人:
MICHAEL SHILOH
金额:
$70.77万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-08 至 2026-02-28
关键词:
AerosolsAnimal ModelAnimalsBacteriaBindingBiochemical GeneticsBiochemistryBiologicalBiological AssayBiological ModelsCRISPR/Cas technologyCaviaCellsCholera ToxinComplexCoughingDataDiarrheaDiseaseElectrophysiology (science)FoundationsFutureG-Protein-Coupled ReceptorsGenesGeneticGenus MycobacteriumGlycolipidsGoalsHumanImmunohistochemistryIndividualInfectionKnock-outLaboratoriesLipidsMeasuresMediatingMediationModelingMolecularMolecular BiologyMycobacterium tuberculosisNebulizerNeuronsNociceptionOrphanPainPersonsPhenolsPopulationPrevalenceProductionProteinsRecording of previous eventsResearchRouteSignal TransductionSymptomsSystemTechniquesTestingTissuesTuberculosisVibrio choleraeVirulenceVirulentWorkWorld Healthaerosolizeddisease transmissionepidemiology studygenetic approachglycolipid receptorhuman diseasein vivoinhibitor/antagonistinsightmutantmycobacterialnovelparticlepathogenpathogenic bacteriapolyketide synthaseprotein complexreceptorresponsescreeningsuccesssulfolipidssulfotransferasetransmission process
中文摘要
项目摘要
任何细菌病原体的成功最终取决于其繁殖和传播到新宿主的能力。
结核分枝杆菌(Mycobacterium tuberculosis,Mtb)是人类结核病的病原体,也是最常见的结核病之一。
人类历史上成功的病原体,也可能采用复杂的手段从一个人传播到另一个人。
其次,包括介导干酪化、组织破坏和空气传播。然而,尽管Mtb付出了代价,
尽管结核病已成为世界卫生的一个重要问题,但负责结核病传播的分子机制仍然难以捉摸。一
活动性结核病的主要症状是咳嗽,而咳嗽是主要的传播机制。虽然
咳嗽是Mtb雾化和传播的一个主要途径,但人们对Mtb雾化和传播的因素知之甚少。
在感染期间产生咳嗽。此外,流行病学研究表明,结核分枝杆菌菌株
代表特定谱系的基因在人类中更普遍,但流行率的差异是否是由于
细菌传播性的差异和相关因素,如咳嗽诱导和雾化,
细菌未知。因此,迫切需要更好地表征结核病的传播动力学
以及咳嗽与传播的关系。因为伤害感受神经元介导咳嗽,
包括分枝杆菌分泌针对神经元的复杂分子,我们假设Mtb产生
分子来触发伤害感受神经元激活咳嗽反应,从而促进传输。我们
发现并鉴定了一种这样的分子--硫脂-1的活性,最近又鉴定了第二种
由毒性分枝杆菌产生的分子。在拟议的研究中,我们将(1)识别和研究
sulfolid-1受体在神经元和实验动物中的表达,(2)表征第二伤害性感受的活性
分子在神经元和实验动物,并确定如何结合其活动与硫脂-1
(3)开发和使用先进的结核病传播系统,以测量传播、咳嗽和雾化
颗粒安全和定量,并使用该系统来比较各种Mtb的传输率
缺乏咳嗽诱导分子的突变体。这项拟议的工作预计将确定新的因素,
与伤害性神经元激活、咳嗽和分枝杆菌传播有关。
英文摘要
Project Abstract
The success of any bacterial pathogen ultimately depends on its ability to multiply and transmit to new hosts.
Mycobacterium tuberculosis (Mtb), the causative agent of the human disease tuberculosis and one of the most
successful pathogens in human history, likely also employs sophisticated means to spread from one person to
the next, including mediating caseation, tissue destruction, and airborne transmission. Yet, despite the toll Mtb
has taken on world health, the molecular mechanisms responsible for Mtb transmission remain elusive. A
major symptom of active tuberculosis is cough, and cough is a major mechanism of transmission. Although
cough is a major route of aerosolization and transmission of Mtb, very little is known about the factors that
produce cough during infection. Furthermore, epidemiologic studies have demonstrated that Mtb strains
representing specific lineages are more prevalent in humans but whether differences in prevalence are due to
differences in bacterial transmissibility and associated factors such as cough induction and aerosolization of
bacteria is unknown. Thus, there is an urgent need to better characterize the transmission dynamics of Mtb
and the relationship of cough to transmission. Because nociceptive neurons mediate cough, and some bacteria
including mycobacteria secrete complex molecules targeting neurons, we hypothesized that Mtb produces
molecules to trigger nociceptive neurons to activate the cough response, thereby facilitating transmission. We
discovered and characterized the activity of one such molecule, sulfolipid-1, and recently identified a second
molecule produced by virulent mycobacteria. In the proposed research we will (1) Identify and study the
sulfolid-1 receptor in neurons and experimental animals, (2) Characterize the activity of the second nociceptive
molecule in neurons and experimental animals, and determine how its activity combines with that of sulfolipid-1
(3) Develop and use a sophisticated Mtb transmission system to measure transmission, cough and aerosolized
particles safely and quantitatively and use the system to compare the transmissibility of a variety of Mtb
mutants lacking cough-inducing molecules. The proposed work is expected to identify novel factors associated
with nociceptive neuron activation, cough and mycobacterial transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of cough in Mycobacterium tuberculosis transmission
-
批准号:10368154
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
-
批准号:10404532
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Mechanisms of cough in Mycobacterium tuberculosis transmission
-
批准号:10578845
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
-
批准号:10190651
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
-
批准号:10610926
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2021
-
负责人:MICHAEL SHILOH
-
依托单位:
RP4: Harnessing autophagy to treat tuberculosis
-
批准号:10573263
-
项目类别:
-
资助金额:$155.64万
-
财政年份:2019
-
负责人:MICHAEL SHILOH
-
依托单位:
RP4: Harnessing autophagy to treat tuberculosis
-
批准号:10364726
-
项目类别:
-
资助金额:$143.51万
-
财政年份:2019
-
负责人:MICHAEL SHILOH
-
依托单位:
Human airway microfold cells in mucosal immunity to bacterial pathogens
-
批准号:9170079
-
项目类别:
-
资助金额:$45.64万
-
财政年份:2016
-
负责人:MICHAEL SHILOH
-
依托单位:
Identification of novel M. tuberculosis secreted effector proteins
-
批准号:8796158
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2014
-
负责人:MICHAEL SHILOH
-
依托单位:
Identification of novel M. tuberculosis secreted effector proteins
-
批准号:8682011
-
项目类别:
-
资助金额:$19.53万
-
财政年份:2014
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8900916
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8438755
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8711263
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:9113479
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
-
批准号:8554358
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2012
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:7846226
-
项目类别:
-
资助金额:$5.59万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:8234541
-
项目类别:
-
资助金额:$6.59万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:7532872
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
Carbon monoxide in Mycobacterium tuberculosis pathogenesis
-
批准号:7631191
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2008
-
负责人:MICHAEL SHILOH
-
依托单位:
RP4: Harnessing autophagy to treat tuberculosis
-
批准号:9893814
-
项目类别:
-
资助金额:$174.07万
-
财政年份:--
-
负责人:MICHAEL SHILOH
-
依托单位:
海外基金